
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 65
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT04028492 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | ||
NCT03568331 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) | ||
NCT04652882 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | ||
NCT04819776 | Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder | ||
NCT01402076 | A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects | ||
NCT05344365 | A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis | ||
NCT01578057 | Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol | ||
NCT04353401 | WGS Analysis of COVID-19 Positive Patients | ||
NCT01526746 | Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function | ||
NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | ||
NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | ||
NCT03838926 | Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies | ||
NCT06296966 | A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | ||
NCT06323655 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects | ||
NCT02970968 | Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis | ||
NCT01919944 | Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P | ||
NCT03772340 | Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
NCT00548340 | VEC-162 Study in Adult Patients With Primary Insomnia | ||
NCT03373201 | Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | ||
NCT01218789 | Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception | ||
NCT04127058 | Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia | ||
NCT06701396 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant | ||
NCT01195558 | Patient Registry of Blind Subjects With Sleep-related Problems | ||
NCT01495169 | Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients | ||
NCT05572281 | Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers | ||
NCT02004041 | Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis | ||
NCT00467441 | VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness | ||
NCT03291041 | A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder | ||
NCT01477619 | Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects | ||
NCT05903924 | Motion Serifos: a Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness | ||
NCT04712734 | A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia | ||
NCT01429116 | Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception | ||
NCT02413918 | Iloperidone in Mixed States of Bipolar Disorder | ||
NCT01637636 | Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. | ||
NCT06138613 | Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness | ||
NCT02130999 | Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™) | ||
NCT06803290 | Food Effect Study of VHX-896 in Healthy Volunteers | ||
NCT02231008 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | ||
NCT02651714 | Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis | ||
NCT04140695 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) | ||
NCT05922995 | The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD) | ||
NCT04849559 | Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers | ||
NCT01348100 | Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients | ||
NCT01540500 | Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine | ||
NCT01163032 | Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder | ||
NCT02560103 | An Observational Study to Investigate the Effects of Rapid Transmeridian Travel | ||
NCT06804603 | A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use | ||
NCT00254202 | Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia | ||
NCT04474990 | Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis | ||
NCT01271387 | Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment |